rVA576
AK581
Phase 3 small_molecule terminated
Quick answer
rVA576 for Paroxysmal Nocturnal Hemoglobinuria is a Phase 3 program (small_molecule) at Akari Therapeutics Plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Akari Therapeutics Plc
- Indication
- Paroxysmal Nocturnal Hemoglobinuria
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated